Download PDF
Pharmacopsychiatry 2015; 48(04/05): 141-144
DOI: 10.1055/s-0035-1549928
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial

J. Sarris
1   The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Richmond, Melbourne, Australia
2   Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, Australia
,
L. H. Price
3   Mood Disorders Research Program and Laboratory for Clinical and Translational Neuroscience, Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA
,
L. L. Carpenter
3   Mood Disorders Research Program and Laboratory for Clinical and Translational Neuroscience, Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA
,
A. R. Tyrka
3   Mood Disorders Research Program and Laboratory for Clinical and Translational Neuroscience, Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA
,
C. H. Ng
1   The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Richmond, Melbourne, Australia
,
G. I. Papakostas
4   Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
,
A. Jaeger
4   Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
,
M. Fava
4   Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
,
D. Mischoulon
4   Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
› Author Affiliations
Further Information

Publication History

received 02 February 2015
revised 16 March 2015

accepted 07 April 2015

Publication Date:
26 May 2015 (online)

Also available at
    Permissions and Reprints

Abstract

Objective: The aim of this study was to examine whether gender differences may have affected treatment response to S-adenosyl methionine (SAMe) in a recent failed randomized clinical trial (RCT) for adults with major depressive disorder.

Methods: Data from a 2-site, 12-week, double-blind RCT (n=189) assessing the efficacy of SAMe vs. placebo and a comparator selective serotonin reuptake inhibitor (escitalopram) were subjected to post-hoc analyses to evaluate effects of patient gender on treatment response.

Results: When assessing the efficacy outcomes within each gender separately, SAMe was superior to placebo among males (n=51), but not among females (n=62). Males showed a significant reduction of depression severity from baseline to study endpoint on the 17-item Hamilton Depression Rating Scale (4.3 point difference; p=0.034; d=0.95), while females did not show significant change. This finding emerged despite equivalence on baseline measures of depression severity between the gender groups.

Conclusion: Results of this secondary data analysis suggest that gender might impact the antidepressant efficacy of SAMe, with greater therapeutic effect found in males. The underlying mechanism is still relatively unknown. Further work is needed to replicate this observation in independent samples.

Clinicaltrials.gov identifier: NCT00101452

Key words

S-adenosyl methionine - SAMe - antidepressant - gender - depression - RCT - one-carbon cycle
 

  • References

  • 1 Williams AL, Girard C, Jui D et al. S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. Clin Invest Med 2005; 28: 132-139
    PubMedGoogle Scholar
  • 2 Bottiglieri T, Hyland K. S-adenosylmethionine levels in psychiatric and neurological disorders: a review. Acta Neurol Scand Suppl 1994; 154: 19-26
    PubMedGoogle Scholar
  • 3 Papakostas GI, Alpert JE, Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Curr Psychiatry Rep 2003; 5: 460-466
    CrossrefPubMedGoogle Scholar
  • 4 Papakostas GI. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. J Clin Psychiatry 2009; 70 (Suppl. 05) 18-22
    CrossrefPubMedGoogle Scholar
  • 5 Papakostas GI, Mischoulon D, Shyu I et al. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 2010; 167: 942-948
    CrossrefPubMedGoogle Scholar
  • 6 Mischoulon D, Price LH, Carpenter LL et al. A Double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry 2014; 75: 370-376
    CrossrefPubMedGoogle Scholar
  • 7 Sarris J, Papakostas G, Vitolo O et al. S-Adenosyl methionine (SAMe) versus escitalopram and placebo in major depression: efficacy and effects of histamine and carnitine as moderators of response. J Affect Dis 2014; 164: 76-81
    CrossrefPubMedGoogle Scholar
  • 8 Kornstein SG, Schatzberg AF, Thase ME et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000; 157: 1445-1452
    CrossrefPubMedGoogle Scholar
  • 9 Koch G, Johansson U, Arvidsson E. Radioenzymatic determination of epinephrine, norepinephrine and dopamine in 0.1 ml plasma samples: plasma catecholamine response to submaximal and near maximal exercise. J Clin Chem Clinical Biochem 1980; 18: 367-372
    PubMedGoogle Scholar
  • 10 Inoue-Choi M, Nelson HH, Robien K et al. One-carbon metabolism nutrient status and plasma S-adenosylmethionine concentrations in middle-aged and older Chinese in Singapore. Int J Mol Epidemiol Genet 2012; 3: 160-173
    PubMedGoogle Scholar
  • 11 King WD, Ho V, Dodds L et al. Relationships among biomarkers of one-carbon metabolism. Mol Biol Rep 2012; 39: 7805-7812
    CrossrefPubMedGoogle Scholar
  • 12 Dording CM, Mischoulon D, Shyu I et al. SAMe and sexual functioning. Eur Psychiatry 2012; 27: 451-454
    CrossrefPubMedGoogle Scholar
  • 13 Strous RD, Ritsner MS, Adler S et al. Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia. Eur Neuropsychopharmacol 2009; 19: 14-22
    CrossrefPubMedGoogle Scholar
  • 14 Witham KL, Butcher NJ, Sugamori KS et al. 5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6 J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion. PLoS One 2013; 8: e77923
    CrossrefPubMedGoogle Scholar
  • 15 McMullen MH, Rowling MJ, Ozias MK et al. Activation and induction of glycine N-methyltransferase by retinoids are tissue- and gender-specific. Arch Biochem Biophys 2002; 401: 73-80
    CrossrefPubMedGoogle Scholar
  • 16 Oscarsson J, Gardmo C, Eden S et al. Pulsatile growth hormone secretion decreases S-adenosylmethionine synthetase in rat liver. Am J Physiol Endocrinol Metab 2001; 280: E280-E286
    PubMedGoogle Scholar